INTELLECTUAL PROPERTY
Building the patent estate for archaeal bioplastic production
Exoform is constructing a comprehensive intellectual property portfolio covering the organism engineering, process architecture, and computational design methods required to industrialise PHA production on Haloferax mediterranei. Our filings span the US and international jurisdictions.
Patent Strategy
Our IP strategy is designed to protect the full technology stack: from the engineered enzymes at the molecular level, through the bioprocess architecture at the systems level, to the computational methods that connect the two through rapid and dynamic provisional patent filings.
Prior art and landscape
H. mediterranei has been the subject of academic PHA research since the early 2000s, with approximately 75% of all published work on haloarchaeal PHA production using this organism. This body of prior art establishes the organism's native capabilities; PHBV production, waste feedstock utilisation, osmotic lysis, as publicly known.
Our patent filings do not claim the organism's native properties. They claim specific engineered modifications, process configurations, and computational methods that go beyond what has been published. The distinction between "H. mediterranei can produce PHBV" (prior art) and "this specific PHA synthase variant in H. mediterranei produces a copolymer with this specific composition via this specific tunnel modification" (our claims) is the foundation of our patent strategy.
Disclosure policy
We do not disclose specific amino acid substitutions, enzyme structural coordinates, computational pipeline architectures, engineered strain designations, fermentation parameters, or process configurations prior to patent publication. Provisional application numbers will be listed on this page following their public disclosure at the 12-month filing anniversary.